Pembrolizumab and Daratumumab indication broadening dates and dosages

DOI

This data set contains data on indication broadening dates and dosages for pembrolizumab and daratumumab.

This entry is a one-file data package totaling 42.8 KB, containing a file in .xlsx format.If you use this dataset, please cite: Heine, Renaud (2023). Pembrolizumab and Daratumumab indication broadening dates and dosages. Erasmus University Rotterdam (EUR). Dataset. https://doi.org/10.25397/eur.24057333

Identifier
DOI https://doi.org/10.34894/MIISQV
Metadata Access https://dataverse.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.34894/MIISQV
Provenance
Creator Heine, Renaud
Publisher DataverseNL
Contributor Heine, Renaud
Publication Year 2025
Rights CC-BY-4.0; info:eu-repo/semantics/openAccess; http://creativecommons.org/licenses/by/4.0
OpenAccess true
Contact Heine, Renaud (https://ror.org/057w15z03)
Representation
Resource Type Dataset
Format application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Size 39689
Version 1.0
Discipline Economics; Social and Behavioural Sciences